#Pharmaceuticals

en.killbait.com

Servier Pharmaceuticals Commits to Year-Round Support for Childhood and Blood Cancer Patients

Servier Pharmaceuticals recently shared on LinkedIn that during Childhood Cancer Awareness Month and Blood Cancer Awareness Month, their employees participated in activities to support patients and families affected by childhood and blood cancer. The company emphasized that their commitment to patients extends beyond a single month, stating that 'every month matters when facing a cancer diagnosis.' Employees engaged in educational resources, patient stories, and activities designed to highlight the impact of their work. The post was published on September 18, 2026, and is part of OncoDaily's news feed, which covers various oncology topics including breast cancer, gastrointestinal oncology, genitourinary oncology, lung oncology, hematology, and radiotherapy. OncoDaily is a platform dedicated to providing updates on cancer research, treatments, and awareness campaigns. The company's message underscores the importance of continuous support for cancer patients throughout the year, not just during designated awareness months. This aligns with broader efforts in the oncology community to maintain consistent advocacy and care for those battling cancer. The post also includes references to related articles on childhood cancer and encourages readers to subscribe to OncoDaily's newsletter for the latest updates in oncology. Servier Pharmaceuticals, a key player in the pharmaceutical industry, continues to demonstrate its dedication to improving cancer care and patient outcomes through various initiatives and partnerships.

dlvr.it

Anthropic Opens a Real Lab to Test AI-Driven Drug Discovery

Anthropic is no longer just running algorithms. The AI company has opened a physical biology lab where Claude directs robotic systems to conduct experiments, targeting rare diseases that big pharma has written off as unprofitable. With a $400 million acquisition, a Novartis board member, and deals with Novo Nordisk and Bristol-Myers Squibb, Anthropic is making a serious bet that AI can reshape drug research from the ground up. https://qz.com/anthropic-biology-wet-lab-ai-drug-research-091826

www.spreaker.com

The End Of Depression? Big Pharma’s New Psychedelic Nasal Spray

Is Big Pharma Turning Toad Venom Into Your Next Prescription? 🐸💊 Ever wonder if the secret to curing treatment-resistant depression isn't hidden in a lab, but inside a toad? In this episode, we deep-dive into Dr. Ben Miles' latest bombshell revelation about how the pharmaceutical industry is aggressively pivoting from fringe substances to standardized medical treatments. We’re dissecting the high-stakes world of psychedelic medicine, specifically the controversial acquisition of synthetic toad venom derivatives by Eli Lilly. Are we entering a new era of mental health, or is the medicalization of psychedelics just another way to commodify human consciousness? Why You Need to Hear This: - The Problem with Tripping: We explain why traditional LSD and psilocybin have been a logistical nightmare for clinical trials. - The BPL-003 Breakthrough: Discover how a new nasal spray is stripping away the “melting walls” while keeping the introspective magic—making it a “tripless” clinical dream. - The Future of Neuroplasticity: Could this finally be the rapid-acting solution for millions suffering in silence? We aren’t just reading the news; we’re questioning the ethics, the chemistry, and the corporate takeover of the “shamanic” experience. If you’ve ever felt like modern psychiatry is hitting a dead end, this is the reality check you’ve been waiting for. Warning: This episode might change how you look at your next therapy session—and your local toad. 🍄✨ Ready to change your mind? Hit that subscribe button, drop a comment with your take, and share this with someone who needs to hear the truth about the future of mental health!  

ppc.land

PatientPoint puts 145,000 ad screens inside 32,000 doctors' offices

PatientPoint runs 145,000 ad screens in 32,000 US medical offices as point-of-care pharma spend passes $1.2bn, while car and game ad surfaces lack measurement.

ppc.land

PatientPoint puts 145,000 ad screens inside 32,000 doctors' offices

PatientPoint runs 145,000 ad screens in 32,000 US medical offices as point-of-care pharma spend passes $1.2bn, while car and game ad surfaces lack measurement.